Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Kimura Y, Tsunedomi R, Yoshimura K, et al. Immune Evasion of Hepatoma Cancer Stem-Like cells from natural killer cells. Ann Surg Oncol. 2022;29(12):7423–33.

Article  PubMed  Google Scholar 

Du X, Qi Z, Xu J, et al. Loss of GABARAPL1 confers ferroptosis resistance to cancer stem-like cells in hepatocellular carcinoma. Mol Oncol. 2022;16(20):3703–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang HL, Chen P, Yan HX, et al. Targeting mTORC2/HDAC3 inhibits stemness of Liver Cancer cells against glutamine starvation. Adv Sci (Weinh). 2022;9(20):e2103887.

Article  PubMed  Google Scholar 

Castven D, Czauderna C, Becker D, et al. Acquired Resistance to Antiangiogenic therapies in Hepatocellular Carcinoma is mediated by Yes-Associated protein 1 activation and transient expansion of Stem-Like Cancer cells. Hepatol Commun. 2022;6(5):1140–56.

Article  CAS  PubMed  Google Scholar 

Wang MD, Xiang H, Zhang L, Wang C. Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma. Transl Oncol. 2022;25:101509.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou K, Huo X, Nguyen R, et al. Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model. J Control Release. 2022;341:341–50.

Article  CAS  PubMed  Google Scholar 

Hu Q, Li Y, Chen H, Liao H, He Y, Zheng Q. CCDC88A Post-transcriptionally regulates VEGF via miR-101 and subsequently regulates Hepatocellular Carcinoma. Front Immunol. 2022;13:859331.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Correnti M, Cappon A, Pastore M, et al. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma. Liver Int. 2022;42(1):233–48.

Article  CAS  PubMed  Google Scholar 

Machida K, Tahara SM. Immunotherapy and Microbiota for Targeting of Liver Tumor-initiating stem-like cells. Cancers (Basel). 2022;14(10):2381.

Article  CAS  PubMed  Google Scholar 

Shigesawa T, Maehara O, Suda G, et al. Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling. Carcinogenesis. 2021;42(1):58–69.

Article  CAS  PubMed  Google Scholar 

Yan Q, Fang X, Li C, Lan P, Guan X. Oncofetal proteins and cancer stem cells. Essays Biochem. 2022;66(4):423–33.

Article  CAS  PubMed  Google Scholar 

Lin Q, Wu Z, Yue X, et al. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. EBioMedicine. 2020;53:102676.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Jiang F, Jiao K, et al. De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties. Exp Cell Res. 2020;386(2):111739.

Article  CAS  PubMed  Google Scholar 

Liu H, Song Y, Qiu H, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ. 2020;27(3):966–83.

Article  CAS  PubMed  Google Scholar 

Zhang N, Gao X, Yuan Q, et al. E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1. Clin Epigenetics. 2023;15(1):77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang T, Jiao Z, You Y, et al. Lenvatinib inhibited HCC cell migration and invasion through regulating the transcription and ubiquitination of UHRF1 and DNMT1. Biochem Pharmacol. 2023;210:115489.

Article  CAS  PubMed  Google Scholar 

Chen M, Fang Y, Liang M, et al. The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma. J Transl Med. 2023;21(1):276.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao X, Sheng Y, Yang J, et al. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):179.

Article  PubMed  PubMed Central  Google Scholar 

Wang Q, Liang N, Yang T, et al. DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. J Hepatol. 2021;75(5):1142–53.

Article  CAS  PubMed  Google Scholar 

Li SJ, Wang L, Sun ZX, Sun SJ, Gao J, Ma RL. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1. Eur Rev Med Pharmacol Sci. 2019;23(7):2768–76.

PubMed  Google Scholar 

Masuzaki R, Kanda T, Sasaki R et al. Suppressors of Cytokine Signaling and Hepatocellular Carcinoma. Cancers (Basel). 2022. 14(10).

Kajiyama T, Serada S, Fujimoto M, et al. SOCS1 gene therapy for Head and Neck cancers: an experimental study. Anticancer Res. 2022;42(7):3361–72.

Article  CAS  PubMed  Google Scholar 

Gong H, Tao Y, Xiao S, et al. LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway. Exp Mol Med. 2023;55(4):831–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun H, Li Y, Quan X, et al. PIAS3/SOCS1-STAT3 axis responses to oxidative stress in hepatocellular cancer cells. Am J Transl Res. 2021;13(11):12395–409.

CAS  PubMed  PubMed Central  Google Scholar 

Liu M, Du L, Cheng X, et al. CpG island methylation of suppressor of Cytokine Signaling-1 Gene Induced by HCV is Associated with HCV-Related Hepatocellular Carcinoma. Front Microbiol. 2022;13:679593.

Article  PubMed  PubMed Central  Google Scholar 

Yoshikawa H, Matsubara K, Qian GS, et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001;28(1):29–35.

Article  CAS  PubMed  Google Scholar 

Cabral L, Reyes P, Crocè LS, Tiribelli C, Sukowati C. The relevance of SOCS1 methylation and epigenetic therapy in diverse cell populations of Hepatocellular Carcinoma. Diagnostics (Basel). 2021;11(10):1825.

Article  CAS  PubMed  Google Scholar 

Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 2022;86(Pt 3):622–32.

Article  CAS  PubMed  Google Scholar 

Lee JE, Kim MY. Cancer epigenetics: past, present and future. Semin Cancer Biol. 2022;83:4–14.

Article  CAS  PubMed  Google Scholar 

Nebbioso A, Tambaro FP, Dell’Aversana C, Altucci L. Cancer epigenetics: moving forward. PLoS Genet. 2018;14(6):e1007362.

Article  PubMed  PubMed Central  Google Scholar 

Szczepanek J, Skorupa M, Jarkiewicz-Tretyn J, Cybulski C, Tretyn A. Harnessing epigenetics for breast Cancer therapy: the ro